Andrew Meds Tirzepatide Review: $299/Month Published, Not Sold by the Funnel (2026)

Andrew Meds prices compounded tirzepatide at $299 a month, month to month and auto-renewing, and it prints that figure on an open product page with no account or questionnaire in front of it. The prepay rungs are given as totals as well as rates — $797 for three months, $1,494 for six and $2,748 for twelve — and every saving advertised against them reconciles exactly. Then you press Get Started, and the funnel behind the button sells something else entirely. Everything below was read on 1 September 2026, including three walks of the company's own intake app.¹

Where the price sits, and what it is said to cover

All four tiers are visible text on the tirzepatide page, beside the line "Prices cover your medication and supplies. You only pay for medication if your provider prescribes it." The FAQ says you are billed at the start of each cycle, which is as close to a stated cycle as the site gets. The Terms give no day count, the marketing pages say per month, and the intake app calls the same period a four-week supply.

Neither funnel actually sold tirzepatide

Both GLP-1 product pages hand off to intakes on a separate host, and neither arrives where the page implies. The semaglutide page's Get Started opens a Microdosing Program whose only offer is Semaglutide Microdosing at $99 a month, a program the marketing site never mentions. The tirzepatide page's Get Started runs twenty screens and ends on a select-treatment step carrying one card, Semaglutide Injections. Three semaglutide prices are live at once: $199 published, $99 in one funnel and $149 for a four-week supply in the other. Whether tirzepatide can be bought through the current intake is unresolved.

What the funnel promises that the Terms do not

An oral tirzepatide is advertised on both GLP-1 pages, and its Learn more link resolves to a category page that does not list it; the FAQ says the program offers the two injections. The funnel adds a money-back weight-loss guarantee that the marketing site never mentions and the Terms do not support, refunds there being discretionary and unavailable for partially used periods.

The brand-vs-compounded question

What ships is compounded tirzepatide, prepared to order rather than manufactured as the approved finished drug, and the FAQ concedes as much. The regulatory position is laid out in our guide to compounded tirzepatide's legal status in 2026.

How the care model holds up

Texas law governs, a Houston address and a toll-free line are published, and the prescribing practice is named as Dr Tel X. Set against that, the compounding pharmacy is disclosed only as a class, prescriptions may be transferred between unnamed pharmacies without notice, and no clinician or support hour is published.

Does the drug work? (Separate from the provider)

The seller and the molecule are separate questions, and the molecule answers its own convincingly. SURMOUNT-1 put weight loss at roughly 15% to 21% of body weight across 72 weeks², and SURMOUNT-5 placed tirzepatide ahead of semaglutide in a direct comparison³. Both studied the branded product at approved doses, a distinction our tirzepatide evidence guide works through.

The honest verdict

Andrew Meds does the hard part unusually well and then loses the thread. A rate, four totals and arithmetic that checks out is better disclosure than most providers we review manage, but a price is only worth what the checkout behind it honors, and neither funnel we walked would sell the drug it prices. Bayan Health fails in the opposite direction: its $149 flat figure is unambiguous, but the Terms bind you to a whole 60- or 90-day protocol. Collective is the other useful contrast, publishing a $69 medication price that is only real once you add the $199-a-year membership required to buy it. Our ranked best tirzepatide providers list sets all three against the field.